Free subscription to the Capitol Journal keeps you current on legislative and regulatory news.
States Target School Cell Phone Use At least four states have banned or severely restricted the use of smart phones in schools in the current legislative biennium. Florida became the first state to do...
Compounded Weight-Loss Drugs Creating Headaches for State Regulators With popular weight-loss drugs like Mounjaro, Ozempic and Wegovy in short supply, many doctors, pharmacies and other providers have...
In their seminal book on the American health care system, legendary investigative reporters Donald L. Barlett and James B. Steele offered a disturbing metaphor for the illogical nature of medical pricing...
PA Lawmakers Pass Bill Regulating PBMs The Pennsylvania legislature passed a bill ( HB 1993 ) aimed at increasing oversight of pharmacy benefit managers. If signed by Gov. Josh Shapiro (D), the measure...
In a sign of the times, states have begun pursuing bills that require disclosure of the use of artificial intelligence. In March, Utah Gov. Spencer Cox (R) signed SB 149 , making the state the first...
With popular weight-loss drugs like Mounjaro, Ozempic and Wegovy in short supply, many doctors, pharmacies and other providers have begun offering compounded versions of the drugs tailored to the needs of individual patients. They’re allowed to do so because the active ingredients in the drugs—semaglutide or tirzepatide—are listed on the U.S. Food and Drug Administration’s drug shortage list.
While commercial drugs are regulated by the FDA, states are responsible for the licensing and oversight of compounding pharmacies, and they’re now struggling to stay on top of that job. Idaho and Tennessee recently announced investigations of medical spas and other providers that may have been dispensing compounded weight-loss drugs illegally. And California and other states are considering strengthening their oversight of providers that offer such drugs. (NATIONAL CONFERENCE OF STATE LEGISLATURES)
Vermont Attorney General Charity Clark (D) filed a lawsuit against pharmacy benefit managers Express Scripts and CVS Caremark, accusing them of squeezing out competition and driving up prescription drug costs. The suit claims the two PBMs control more than 95% of Vermont’s pharmacy benefit market, giving them the power to dictate which drugs are covered by insurers. (LAW360)
AstraZeneca and AbbVie have filed lawsuits challenging legislation enacted in Kansas in April (SB 28) preventing drug companies from limiting the ability of pharmacies under contract with eligible hospitals and clinics to obtain outpatient prescription drugs at discounted prices, as provided for by the federal 340B drug discount program. The drug makers claim the federal program wasn’t intended to cover pharmacy chains like CVS and Walgreens. (KANSAS REFLECTOR)
—Compiled by SNCJ Managing Editor KOREY CLARK
Visit our webpage to connect with a LexisNexis® State Net® representative and learn how the State Net legislative and regulatory tracking service can help you identify, track, analyze and report on relevant legislative and regulatory developments.